(Q67292007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Mechanism for reduced drug clearance in patients with cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

author name string

D. Pessayre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A631487

21 August 2023

D. Lebrec

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A631487

21 August 2023

V. Descatoire

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A631487

21 August 2023

M. Peignoux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A631487

21 August 2023

J. P. Benhamou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A631487

21 August 2023

language of work or name

English

0 references

publication date

1 March 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 September 2019

https://api.elsevier.com/content/article/PII:0016508578902974?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

https://api.elsevier.com/content/article/PII:0016508578902974?httpAccept=text/plain

21 August 2023

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

21 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

566-571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:631487%20AND%20SRC:MED&resulttype=core&format=json

A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol

11 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in Humans

21 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

The disposition of propranolol. I. Elimination during oral absorption in man

21 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate

21 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Plasma propranolol levels in adults With observations in four children

21 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Improved fluorimetric assay of plasma propranolol

21 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function

21 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Drug therapy. Clinical Pharmacokinetics (first of two parts).

21 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Commentary: a physiological approach to hepatic drug clearance

21 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Metabolism of amylobarbitone in patients with chronic liver disease

21 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic liver disease

21 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

21 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Intravenous administration of diazepam in patients with chronic liver disease

21 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

The effect of cirrhosis on the disposition and elimination of meperidine in man

21 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Clinical pharmacology of propranolol

21 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green

21 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Hepatic circulation in hepatitis A

21 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

Determination of drug metabolizing enzymes in needle biopsies of human liver

21 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0016-5085(78)90297-4

21 August 2023

Identifiers

1 reference